Skip to main content
. 2022 Jun 16;5:591. doi: 10.1038/s42003-022-03529-z

Table 1.

Novel loci associated with the iron status biomarkers serum iron, TSP, and TIBC in a genome-wide association meta-analysis.

Trait rsID-Alt Effect SE P-value MAF Nearest gene(s) Consequence N Studies
TIBC rs514595-C 0.03 0.005 6.5E−10 0.155 AKR1A1;NASP 208,422 H;M;S;dC;I

TIBC

S-Iron

rs137891701-D

rs61804206-G

0.04

0.03

0.006

0.005

4.9E−9

4.7E−10

0.129

0.142

SDHC;FCGR2A

RPL3P1P11;FCRLA

R2 = 1.00 w/missense

202,496

236,612

H;M;dC;I

H;M;S;dC;I

TIBC rs1435167-A −0.02 0.004 1.6E−10 0.373 EGLN1 R2 = 0.89 w/missense 208,422 H;M;S;dC;I
S-Iron rs7580634-T −0.02 0.003 4.7E−10 0.464 IL1F10;IL1RN 236,612 H;M;S;dC;I
TIBC rs11900910-T 0.02 0.004 2.1E−11 0.451 EPAS1 208,422 H;M;S;dC;I
TIBC rs1861408-T 0.02 0.004 7.8E−10 0.297 SERTAD2;LINC01800 208,422 H;M;S;dC;I
TIBC rs715-C 0.02 0.004 4.5E−10 0.285 CPS1 R2 = 0.92 w/missense 202,496 H;M;S;dC;I
TIBC rs781168893-T −0.75 0.064 2.1E−31 0.003 SLC12A8;ZNF148 56,667 H
S-Iron rs571559677-C −0.35 0.063 3.1E−8 0.002 CLSTN2 67,171 H;M
TIBC rs760897340-G −0.97 0.104 7.5E−21 0.001 DIPK2A;LNCSRLR 56,667 H
TIBC rs969672878-A −0.90 0.103 2.3E−18 0.001 LOC440982;LINC02032 56,667 H
TSP rs218264-T 0.02 0.004 4.2E−8 0.250 LINC02283;LINC02260 198,516 H;M;dC;I
TIBC rs185240714-A −0.07 0.009 2.4E−13 0.040 PELO 204,433 H;M;dC;I
TIBC rs41274050-T 0.13 0.022 4.8E−9 0.008 A1CF 202,496 H;M;dC;I

S-Iron

TIBC

rs10740134-C

rs10740134-C

0.02

0.02

0.003

0.004

7.8E−11

8.9E−10

0.487

0.487

REEP3

REEP3

R2 = 0.96 w/missense

R2 = 0.96 w/missense

236,612

198,516

H;M;S;dC;I

H;M;dC;I

S-Iron rs59213222-D −0.03 0.005 9.3E−9 0.223 ZMIZ1 230,682 H;M;S;dC;I
TIBC rs143878994-A 0.05 0.009 3.6E−8 0.046 ARHGAP20 202,496 H;M;S;dC;I
TIBC rs76895963-G −0.08 0.015 4.2E−8 0.017 CCND2-AS1 202,496 H;M;S;dC;I
TIBC rs3782735-A 0.02 0.004 2.4E−9 0.402 LAG3 202,496 H;M;S;dC;I

S-Iron

TSP

rs2900478-A

rs2900478-A

−0.02

−0.03

0.004

0.005

3.9E−8

1.4E−10

0.178

0.179

SLCO1B1

SLCO1B1

R2 = 0.90 w/missense

R2 = 0.90 w/missense

236,612

198,516

H;M;S;dC;I

H;M;dC;I

TIBC rs1150975-A 0.02 0.004 4.1E−8 0.347 LINC02422;RESF1 202,496 H;M;S;dC;I
TIBC rs77371258-A 0.04 0.006 3.5E−13 0.099 POP5;CABP1 R2 = 0.88 w/missense 202,496 H;M;S;dC;I
S-Iron rs4759827-T −0.02 0.004 1.5E−8 0.279 ADGRD1 236,612 H;M;S;dC;I

S-Iron

TSP

rs1958078-C

rs1958078-C

0.04

0.04

0.005

0.005

1.0E−14

1.7E−11

0.135

0.131

SMOC1

SMOC1

236,612

198,516

H;M;S;dC;I

H;M;dC;I

TIBC rs12879801-G 0.03 0.004 1.5E−17 0.452 ADAM21P1;SYNJ2BP-COX16 202,496 H;M;S;dC;I
TIBC rs11159099-G −0.03 0.004 5.2E−16 0.482 YLPM1 202,496 H;M;S;dC;I
TIBC rs8062982-C 0.03 0.004 6.7E−12 0.401 CHD9;LOC643802 202,496 H;M;S;dC;I
TIBC rs34682685-A 0.04 0.006 1.2E−12 0.100 HPR 202,496 H;M;S;dC;I
TIBC rs2287322-G 0.03 0.004 8.9E−13 0.239 WDR81 R2 = 0.97 w/missense 202,496 H;M;S;dC;I
TIBC rs1292072-G 0.03 0.004 5.0E−11 0.224 VMP1;TUBD1 202,496 H;M;S;dC;I
TIBC rs34284056-A −0.02 0.004 1.6E−8 0.264 ZCCHC2 202,496 H;M;S;dC;I
TIBC rs111234557-G −0.03 0.006 4.0E−9 0.121 MAU2 202,496 H;M;S;dC;I
TIBC rs12976652-C −0.05 0.006 6.5E−18 0.105 MYPOP 202,496 H;M;S;dC;I

S-Iron

TIBC

rs1800961-T

rs1800961-T

0.04

0.05

0.008

0.009

2.4E−8

4.0E−9

0.047

0.047

HNF4A

HNF4A

Missense

Missense

236,612

202,496

H;M;S;dC;I

H;M;S;dC;I

S-Iron

TSP

rs3747207-A

rs3747207-A

0.03

0.02

0.004

0.004

1.7E−12

1.1E−8

0.234

0.233

PNPLA3

PNPLA3

R2 = 1.00 w/missense

R2 = 1.00 w/missense

236,612

198,516

H;M;S;dC,I

H;M;dC;I

Associated traits: Serum iron (S-iron), Transferrin Saturation Percentage (TSP), Total Iron Binding Capacity (TIBC). Locus index variant with alternate allele/indel (rsID-Alt, D = deletion) per associated trait. Effect size and direction (Effect) with standard error (SE) and functional consequence (correlation R2 reported if index variant is strongly correlated (R2 > 0.8) with a missense variant.) is given for the alternate variant. Minor allele frequency (MAF), sample size (N), studies: HUNT (H), MGI (M), deCODE (dC), Interval (I), SardiNIA (S), DBDS (D). See Supplementary Data 1 for further details.